Clinical Trial Update: DDI HV (ATV - Merck) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for atazanavir (ATV) related to HIV infections; the study status is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• REYATAZ (atazanavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | Phase 1 | Status: COMPLETED